Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 565-569

  Kato, Yasuhito ^a   Yamashita, Tsuyoshi ^a   Ishikawa, Mutsuo ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Cervical cancer; Invasion assay; MMP inhibitor; MMP 2; MMP 9; Real time PCR; Zymography

Indexed keywords

1,10 PHENANTHROLINE; 1,10-PHENANTHROLINE; GELATINASE A; GELATINASE B; MESSENGER RNA; PHENANTHROLINE DERIVATIVE; PROTEINASE INHIBITOR;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL CULTURE; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR;

FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHENANTHROLINES; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0036581406     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.565     Document Type: Article

References (31)

1. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991. (Pubitemid 121001258)
3. Lynn MM: The matrix-degrading metalloproteinases. Bioessays 14: 455-463, 1992.
4. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993. (Pubitemid 23342150)
5. Yong VW, Krekoski CA, Forsyth PA, Bell R and Edwards DR: Matrix metalloproteinases and diseases of the CNS. TINS 21: 75-80, 1998.
6. Makowski GS and Ramsby ML: Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation. Biochem Mol Biol Int 46: 1043-1053, 1998. (Pubitemid 29004615)
7. Rougier JP, Moullier P, Piedagnel R and Ronco PM: Hyperosmolality suppresses but TGFB1 increases MMP-9 in human peritoneal mesothelial cells. Kidney Int 51: 337-347, 1997. (Pubitemid 27064556)
8. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA and Lim MS: The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes 20: S9-S15, 1996. (Pubitemid 26108576)
9. Kenagy RD, Hart CE, Stetler-Stevenson WG and Clowes AW: Primate smooth muscle cell migration form aortic expiants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96: 3555-3560, 1997. (Pubitemid 27513433)
10. Tsuda TT, Kodama A, Yamamura M, Matsuzaki S and Tsuda M: Isolation and characterization of a high molecular weight type IV collagenase isolated from human carcinoma tissue. FEBS Lett 319: 35-39, 1993. (Pubitemid 23074265)
11. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE and Salamonsen LA: Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79: 530-536, 1994.
12. Kusukawa J, Sasaguri Y, Shima I, Kameyama T and Morimatsu M: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 99: 18-23, 1993. (Pubitemid 23030665)
13. Xiaoming L, Xin Z and Shuyi M: Secretion of 92 kDa gelatinase (MMP9) by bovine neutrophils. Vet Immunol Immunopathol 67: 247-258, 1999.
14. Peters TJ, Albieri A, Bevilacqua E, Chapman BM, Crane LH, Hamlin GP, Seiki M and Soares MJ: Differentiation-dependent expression of gelatinase-B/matrix metalloproteinase-9 in trophoblast cells. Cell Tissue Res 295: 287-296, 1999. (Pubitemid 29050261)
15. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PMA, Sutherland G and Edwards DR: Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828-1835, 1999. (Pubitemid 29132312)
16. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987. (Pubitemid 17082655)
17. Yoshizaki T, Maruyama Y, Sato H and Furukawa M: Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95: 44-55, 2001.
18. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS and Seiki M: Increased expression of membrane type-1 matrix metalloproteinase in head and neck carcinoma. Cancer 79: 139-144, 1997. (Pubitemid 26425519)
19. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD and Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993. (Pubitemid 23147516)
20. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y and Seiki M: Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64: 355-359, 1995.
21. Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
22. Bramhall SR: The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int J Pancreatol 21: 1-12, 1997.
23. Sillem M, Prifti S, Koumouridis A and Runnebaum B: Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines. Eur J Gynaec Oncol 5-6: 367-370, 1999.
24. Tamakoshi K, Kikkawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, Yamagata S, Suganuma N and Tomoda Y: Characterization of extracellular matrix-degrading proteinase and its inhibitior in gynecologic cancer tissues with clinically different metastatic form. Cancer 76: 2565-2571, 1995.
25. Nuovo GJ, MacConnell PB, Simsir A, Valnea F and French DL: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267-275, 1995.
26. Boyd RS and Balkwill FR: MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br J Cancer 80: 315-321, 1999. (Pubitemid 29213179)
27. Kitagawa Y, Kunimi K, Uchibayashi T, Sato H and Namiki M: Expression of messenger rnas for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 162: 905-909, 1999. (Pubitemid 29436915)
28. Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193, 2001. (Pubitemid 32166488)
29. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD and Hardcastle JD: Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 55: 3629-3633, 1995.
30. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W and Brown PD: Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 56: 2815-2822, 1996.
31. Matsushita A, Onda M, Uchida E, Maekawa R and Yoshioka T: Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer. Int J Cancer 92: 434-440, 2001. (Pubitemid 32249723)